137 related articles for article (PubMed ID: 21560128)
1. Analysis of matrix dosage forms during dissolution testing using raman microscopy.
Haaser M; Windbergs M; McGoverin CM; Kleinebudde P; Rades T; Gordon KC; Strachan CJ
J Pharm Sci; 2011 Oct; 100(10):4452-9. PubMed ID: 21560128
[TBL] [Abstract][Full Text] [Related]
2. Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping.
Windbergs M; Haaser M; McGoverin CM; Gordon KC; Kleinebudde P; Strachan CJ
J Pharm Sci; 2010 Mar; 99(3):1464-75. PubMed ID: 19691104
[TBL] [Abstract][Full Text] [Related]
3. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-Stokes Raman scattering microscopy.
Windbergs M; Jurna M; Offerhaus HL; Herek JL; Kleinebudde P; Strachan CJ
Anal Chem; 2009 Mar; 81(6):2085-91. PubMed ID: 19209888
[TBL] [Abstract][Full Text] [Related]
4. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
Windbergs M; Strachan CJ; Kleinebudde P
J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
[TBL] [Abstract][Full Text] [Related]
5. In situ dissolution analysis using coherent anti-Stokes Raman scattering (CARS) and hyperspectral CARS microscopy.
Fussell A; Garbacik E; Offerhaus H; Kleinebudde P; Strachan C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1141-7. PubMed ID: 23994672
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
7. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution.
Nagy ZK; Balogh A; Vajna B; Farkas A; Patyi G; Kramarics A; Marosi G
J Pharm Sci; 2012 Jan; 101(1):322-32. PubMed ID: 21918982
[TBL] [Abstract][Full Text] [Related]
8. Two-step solid lipid extrusion as a process to modify dissolution behavior.
Windbergs M; Gueres S; Strachan CJ; Kleinebudde P
AAPS PharmSciTech; 2010 Mar; 11(1):2-8. PubMed ID: 20309654
[TBL] [Abstract][Full Text] [Related]
9. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
Jannin V; Pochard E; Chambin O
Int J Pharm; 2006 Feb; 309(1-2):6-15. PubMed ID: 16376034
[TBL] [Abstract][Full Text] [Related]
10. Influence of structural variations on drug release from lipid/polyethylene glycol matrices.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Sci; 2009 Jul; 37(5):555-62. PubMed ID: 19406229
[TBL] [Abstract][Full Text] [Related]
11. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic matrices: application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release.
El-Malah Y; Nazzal S
Int J Pharm; 2006 Feb; 309(1-2):163-70. PubMed ID: 16413978
[TBL] [Abstract][Full Text] [Related]
13. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
14. Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.
Liu Q; Fassihi R
J Pharm Pharmacol; 2009 Jul; 61(7):861-7. PubMed ID: 19589227
[TBL] [Abstract][Full Text] [Related]
15. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
16. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
Ferrero C; Jiménez-Castellanos MR
Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
[TBL] [Abstract][Full Text] [Related]
17. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Verstraete G; Van Renterghem J; Van Bockstal PJ; Kasmi S; De Geest BG; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):214-21. PubMed ID: 27113866
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
[TBL] [Abstract][Full Text] [Related]
19. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous UV imaging and raman spectroscopy for the measurement of solvent-mediated phase transformations during dissolution testing.
Østergaard J; Wu JX; Naelapää K; Boetker JP; Jensen H; Rantanen J
J Pharm Sci; 2014 Apr; 103(4):1149-56. PubMed ID: 24496995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
